Veradigm Price to Sales Ratio 2012-2022 | MDRX

Historical PS ratio values for Veradigm (MDRX) over the last 10 years. The current P/S ratio for Veradigm as of September 18, 2026 is .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Veradigm P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2026-09-18 4.70 0.99
2022-12-31 17.64 $4.75 3.71
2022-09-30 15.23 $4.62 3.30
2022-06-30 14.83 $4.54 3.27
2022-03-31 22.52 $4.24 5.31
2021-12-31 18.45 $4.11 4.49
2021-09-30 13.37 $-0.55 0.00
2021-06-30 18.51 $0.62 29.85
2021-03-31 15.02 $1.92 7.83
2020-12-31 14.44 $3.37 4.29
2020-09-30 8.14 $8.76 0.93
2020-06-30 6.77 $9.16 0.74
2020-03-31 7.04 $9.56 0.74
2019-12-31 9.82 $9.76 1.01
2019-09-30 10.98 $9.64 1.14
2019-06-30 11.63 $9.45 1.23
2019-03-31 9.54 $9.24 1.03
2018-12-31 9.64 $9.11 1.06
2018-09-30 14.25 $8.50 1.68
2018-06-30 12.00 $8.52 1.41
2018-03-31 12.35 $8.40 1.47
2017-12-31 14.55 $8.28 1.76
2017-09-30 14.23 $8.53 1.67
2017-06-30 12.76 $8.15 1.57
2017-03-31 12.68 $7.87 1.61
2016-12-31 10.21 $7.39 1.38
2016-09-30 13.17 $7.86 1.68
2016-06-30 12.70 $7.62 1.67
2016-03-31 13.21 $7.49 1.76
2015-12-31 15.38 $7.53 2.04
2015-09-30 12.40 $7.56 1.64
2015-06-30 13.68 $7.60 1.80
2015-03-31 11.96 $7.62 1.57
2014-12-31 12.77 $7.67 1.67
2014-09-30 13.42 $7.75 1.73
2014-06-30 16.05 $7.69 2.09
2014-03-31 18.03 $7.68 2.35
2013-12-31 15.46 $7.78 1.99
2013-09-30 14.87 $7.76 1.92
2013-06-30 12.94 $7.99 1.62
2013-03-31 13.59 $8.05 1.69
2012-12-31 9.42 $7.95 1.19
2012-09-30 12.42 $8.02 1.55
2012-06-30 10.93 $7.83 1.40
2012-03-31 16.60 $7.67 2.16
2011-12-31 18.94 $7.52 2.52
2011-09-30 18.02 $7.18 2.51
2011-06-30 19.42 $6.80 2.86
2011-03-31 20.99 $6.23 3.37
2010-12-31 19.27 $4.49 4.29
2010-09-30 18.47 $4.04 4.58
2010-06-30 16.10 $3.73 4.31
2010-05-31 18.81 $2.45 7.66
2010-03-31 19.58 $3.58 5.47
2010-02-28 17.89 $3.46 5.18
2009-12-31 20.23 $3.34 6.06
2009-11-30 19.20 $3.34 5.75
2009-09-30 20.27 $3.28 6.18
2009-08-31 14.85 $3.24 4.58
2009-05-31 12.91 $3.55 3.64
2009-02-28 8.70 $4.67 1.86
2008-11-30 7.70 $5.01 1.54
2008-09-30 6.61 $3.94 1.68
2008-08-31 7.62 $3.78 2.01
2008-06-30 6.59 $3.84 1.72
2008-05-31 6.60 $3.62 1.83
2008-03-31 5.48 $4.78 1.15
2008-02-29 5.67 $4.60 1.23
2007-12-31 10.32 $4.51 2.29
2007-11-30 9.40 $5.42 1.73
2007-09-30 14.36 $5.27 2.73
2007-06-30 13.54 $5.39 2.51
2007-05-31 13.05 $5.42 2.41
2007-03-31 14.25 $4.40 3.24
2006-12-31 14.34 $4.27 3.36
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.587B $0.594B
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $42.703B 42.61
Tempus AI (TEM) United States $14.500B 0.00
10x Genomics (TXG) United States $10.029B 0.00
Hinge Health (HNGE) United States $7.643B 73.43
Hims & Hers Health (HIMS) United States $6.507B 0.00
Doximity (DOCS) United States $4.736B 29.20
Heartflow (HTFL) United States $4.310B 0.00
IRhythm Holdings (IRTC) United States $3.684B 242.93
Privia Health (PRVA) United States $2.566B 95.67
Clover Health Investments (CLOV) United States $2.411B 0.00
Schrodinger (SDGR) United States $2.232B 0.00
Butterfly Network (BFLY) United States $2.120B 0.00
Inspire Medical Systems (INSP) United States $2.103B 32.04
Omnicell (OMCL) United States $1.484B 21.18
Azenta (AZTA) United States $1.473B 80.07
Enovis (ENOV) United States $1.027B 5.31
Talkspace (TALK) United States $0.879B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.716B 0.00
Phreesia (PHR) United States $0.638B 34.27
Fulgent Genetics (FLGT) United States $0.601B 0.00
Claritev (CTEV) United States $0.538B 0.00
Carlsmed (CARL) United States $0.420B 0.00
Evolent Health (EVH) United States $0.415B 0.00
Senseonics Holdings (SENS) United States $0.394B 0.00
CapsoVision (CV) United States $0.317B 0.00
Standard BioTools (LAB) United States $0.287B 0.00
American Well (AMWL) United States $0.226B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Health Catalyst (HCAT) United States $0.135B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.129B 0.00
CareCloud (CCLD) United States $0.094B 6.94
Pulmonx (LUNG) United States $0.085B 0.00
Zepp Health (ZEPP) Netherlands $0.065B 0.00
Outset Medical (OM) United States $0.058B 0.00
Nyxoah SA (NYXH) Belgium $0.058B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
EUDA Health Holdings (EUDA) Singapore $0.052B 0.00
Precipio (PRPO) United States $0.047B 0.00
MDxHealth SA (MDXH) Belgium $0.033B 0.00
111 (YI) China $0.031B 0.00
Evaxion - (EVAX) Denmark $0.027B 0.00
HeartBeam (BEAT) United States $0.024B 0.00
HeartSciences (HSCS) United States $0.023B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
DataMeds AI (MEDS) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.009B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00
PROFUSA (PFSA) United States $0.001B 0.00
Zhongchao (ZCMD) China $0.001B 0.00
TruBridge (TBRG) United States $0.000B 0.00